Risk of Acute Myocardial Infarction Among New Users of Allopurinol According to Serum Urate Level: A Nested Case-Control Study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of Acute Myocardial Infarction Among New Users of Allopurinol According to Serum Urate Level: A Nested Case-Control Study
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 8, Issue 12, Pages 2150
Publisher
MDPI AG
Online
2019-12-06
DOI
10.3390/jcm8122150
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hyperuricaemia and vascular risk
- (2019) Matteo Landolfo et al. CURRENT OPINION IN CARDIOLOGY
- Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study
- (2018) Sarah F Keller et al. ANNALS OF THE RHEUMATIC DISEASES
- Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials
- (2018) Markus Bredemeier et al. BMC Cardiovascular Disorders
- An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout
- (2018) Rishi J. Desai et al. PLoS One
- Gout and cardiovascular disease
- (2018) Aryeh M. Abeles et al. CURRENT OPINION IN RHEUMATOLOGY
- Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study
- (2018) Sara Rodríguez-Martín et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis
- (2017) Tony Zhang et al. RHEUMATOLOGY
- Cardiac and renal protective effects of urate-lowering therapy
- (2017) Pascal Richette et al. RHEUMATOLOGY
- Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution
- (2017) Lisa Stamp et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Asymptomatic hyperuricemia and coronary artery disease in elderly patients without comorbidities
- (2017) Junnan Wu et al. Oncotarget
- Effect of Allopurinol on Cardiovascular Outcomes in Hyperuricemic Patients: A Cohort Study
- (2016) Kasper Søltoft Larsen et al. AMERICAN JOURNAL OF MEDICINE
- 2016 updated EULAR evidence-based recommendations for the management of gout
- (2016) P Richette et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of Urate Level on Cardiovascular Risk in Allopurinol Treated Patients. A Nested Case-Control Study
- (2016) Kasper Søltoft Larsen et al. PLoS One
- Effects of Xanthine Oxidase Inhibitors on Cardiovascular Disease in Patients with Gout: A Cohort Study
- (2015) Seoyoung C. Kim et al. AMERICAN JOURNAL OF MEDICINE
- Allopurinol use and risk of non-fatal acute myocardial infarction
- (2015) Francisco J de Abajo et al. HEART
- Effect of Urate-lowering Therapy on the Risk of Cardiovascular Disease and All-cause Mortality in Patients with Gout: A Case-matched Cohort Study
- (2015) J.-H. Chen et al. JOURNAL OF RHEUMATOLOGY
- Risk of ischemic stroke associated with non-steroidal anti-inflammatory drugs and paracetamol: a population-based case-control study
- (2015) P. García-Poza et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Allopurinol Use and Risk of Fatal Hypersensitivity Reactions
- (2015) Chien-Yi Yang et al. JAMA Internal Medicine
- Impact of allopurinol on risk of myocardial infarction
- (2014) L Grimaldi-Bensouda et al. ANNALS OF THE RHEUMATIC DISEASES
- Improving cardiovascular and renal outcomes in gout: what should we target?
- (2014) Pascal Richette et al. Nature Reviews Rheumatology
- Risk of nonfatal acute myocardial infarction associated with non-steroidal antiinflammatory drugs, non-narcotic analgesics and other drugs used in osteoarthritis: a nested case-control study
- (2014) Francisco J. de Abajo et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Allopurinol Therapy in Gout Patients Does Not Associate with Beneficial Cardiovascular Outcomes: A Population-Based Matched-Cohort Study
- (2014) Victor C. Kok et al. PLoS One
- The role of uric acid in the pathogenesis of human cardiovascular disease
- (2013) Mehmet Kanbay et al. HEART
- Allopurinol: novel indications in cardiovascular disease
- (2012) Allan Struthers et al. HEART
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- Multiple imputation by chained equations: what is it and how does it work?
- (2011) Melissa J. Azur et al. INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH
- Mechanistic Insights Into the Therapeutic Use of High-Dose Allopurinol in Angina Pectoris
- (2011) Narasimharajapura S. Rajendra et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Gout. Epidemiology of gout
- (2011) Edward Roddy et al. ARTHRITIS RESEARCH & THERAPY
- Impact of allopurinol use on urate concentration and cardiovascular outcome
- (2010) Li Wei et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Hyperuricemia and incident hypertension: A systematic review and meta-analysis
- (2010) Peter C. Grayson et al. ARTHRITIS CARE & RESEARCH
- Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel
- (2007) Sima Halevy et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation